Interferons and dry eye in sjögren’s syndrome

Yoko Ogawa, Eisuke Shimizu, Kazuo Tsubota

研究成果: Review article査読

36 被引用数 (Scopus)


Various cytokines, including interferon (IFN)-γ and IL-17, are augmented, and autoreactive T cells and B cells are activated in the immune pathogenesis of Sjögren’s syndrome (SS). In particular, IFNs are involved in both the early stages of innate immunity by high level of type I IFN in glandular tissue and sera and the later stages of disease progression by type I and type II IFN producing T cells and B cells through B cell activating factor in SS. Genetically modified mouse models for some of these molecules have been reported and will be discussed in this review. New findings from human SS and animal models of SS have elucidated some of the mechanisms underlying SS-related dry eye. We will discuss IFN-γ and several other molecules that represent candidate targets for treating inflammation in SS-related dry eye.

ジャーナルInternational journal of molecular sciences
出版ステータスPublished - 2018 11月 10

ASJC Scopus subject areas

  • 触媒
  • 分子生物学
  • 分光学
  • コンピュータ サイエンスの応用
  • 物理化学および理論化学
  • 有機化学
  • 無機化学


「Interferons and dry eye in sjögren’s syndrome」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。